ORIGINAL RESEARCH
Accepted on 05 Aug 2025
Prevalence of risk phenotypes associated with CYP2C9*2, *3 and VKORC1 c.-1639G>A genetic polymorphisms in the world populations: Implications in clinical practice
doi 10.3389/fphar.2025.1597379
- Frontiers in Pharmacology
- Pharmacogenetics and Pharmacogenomics
- Research Topics
- Innovations in Pharmacogenomics: Embracing Diversity and Clinical Application
Innovations in Pharmacogenomics: Embracing Diversity and Clinical Application
1,726
Total downloads
10k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 16 Jul 2025
Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review
doi 10.3389/fphar.2025.1569353
- 920 views
ORIGINAL RESEARCH
Published on 29 May 2025
Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
doi 10.3389/fgene.2025.1574325
- 1,635 views
BRIEF RESEARCH REPORT
Published on 22 May 2025
Implementation and integration of a multidisciplinary pharmacogenomics service in an underserved integrated behavioral health clinic
doi 10.3389/fphar.2025.1594032
- 978 views
ORIGINAL RESEARCH
Published on 28 Apr 2025
Genetic polymorphisms in SLC5A2 are associated with clinical outcomes and dapagliflozin response in heart failure patients
doi 10.3389/fphar.2025.1539870
- 1,831 views
REVIEW
Published on 28 Apr 2025
Research progress on m6A and drug resistance in gastrointestinal tumors
doi 10.3389/fphar.2025.1565738
- 1,154 views
MINI REVIEW
Published on 12 Feb 2025
Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative review
doi 10.3389/fphar.2025.1523399
- 1,532 views
- 1 citation
Published in
Frontiers in Pharmacology
Pharmacogenetics and Pharmacogenomics
Participating Journals
Frontiers in Genetics
- 2.8 impact factor
- 6.2 citescore